ONMD vs NIVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

ONMD

32.2
AI Score
VS
ONMD Wins

NIVF

31.6
AI Score

Investment Advisor Scores

ONMD

32score
Recommendation
SELL

NIVF

32score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ONMD NIVF Winner
Revenue 1.36M 4.73M NIVF
Net Income -2.80M 9.88M NIVF
Gross Margin -37.0% 20.2% NIVF
Net Margin -206.1% 209.0% NIVF
Operating Income -9.67M -10.73M ONMD
ROE 94.5% 37.1% ONMD
ROA -130.2% 30.2% NIVF
Total Assets 2.15M 32.72M NIVF
Cash 585,000 758,621 NIVF
Current Ratio 0.43 3.12 NIVF
Free Cash Flow -7.52M -11.06M ONMD

Relative Price Performance (Last 90 Days)

ONMD 1M: +568.1% · 3M: +677.4% NIVF 1M: +169.9% · 3M: +39.0%

Current Technical Phase

ONMD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (241.6% over 20 days), RSI 64

RSI (14): 64.1 · Price: $4.71

NIVF

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 77

RSI (14): 76.8 · Price: $1.46

Fundamentals Snapshot

Metric ONMD NIVF
Market Cap — —
Forward P/E 0.0 0.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.9% 0.0%
Gross Margin -0.8% 0.2%
Operating Margin -7.7% -1.8%
EPS -1.72 -26766.46
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ONMD is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.